✦ LIBER ✦

Pharmacokinetics of Gemtuzumab Ozogamicin, an Antibody-Targeted Chemotherapy Agent for the Treatment of Patients with Acute Myeloid Leukemia in First Relapse

✍ Scribed by Dowell, James A.; Korth-Bradley, Joan; Liu, Hanjiu; King, S. Peter; Berger, Mark S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antibody-targeted chemotherapy of older

✍ Larson, R A; Boogaerts, M; Estey, E; Karanes, C; Stadtmauer, E A; Sievers, E L; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 163 KB

Fractionated doses of gemtuzumab ozogami

✍ J. V. Malfuson, J. Konopacki, C. Thepenier, H. Eddou, V. Foissaud… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 175 KB

The role of gemtuzumab ozogamicin in com

✍ Hien K. Duong; Matt Kalaycio 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 178 KB

Licensure of Gemtuzumab Ozogamicin for t

✍ Mark S. Berger; Lance H. Leopold; James A. Dowell; Joan M. Korth-Bradley; Matthe 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 141 KB

Successful induction of molecular remiss

✍ R. Swords; P. J. Hayden; K. Molloy; M. Lawlor; P. V. Browne; P. T. Murphy 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

Fractionated gemtuzumab ozogamicin and s

✍ Pilorge, Sylvain; Rigaudeau, Sophie; Rabian, Florence; Sarkozy, Clémentine; Taks 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 482 KB